An inexpensive nonlinear medium for intense ultrabroadband pulse characterization

The ability of pellets made up of compressed iron iodate nanocrystals to frequency-double the whole visible spectrum is demonstrated. We suggest their use for complete characterization of intense ultrabroadband laser pulse

Stellar Diameters and Temperatures – V. 11 Newly Characterized Exoplanet Host Stars

We use near-infrared interferometric data coupled with trigonometric parallax values and spectral energy distribution fitting to directly determine stellar radii, effective temperatures and luminosities for the exoplanet host stars 61 Vir, ρ CrB, GJ 176, GJ 614, GJ 649, GJ 876, HD 1461, HD 7924, HD 33564, HD 107383 and HD 210702. Three of these targets are M dwarfs. Statistical uncertainties in the stellar radii and effective temperatures range from 0.5 to 5 per cent and from 0.2 to 2 per cent, respectively. For eight of these targets, this work presents the first directly determined values of radius and temperature; for the other three, we provide updates to their properties. The stellar fundamental parameters are used to estimate stellar mass and calculate the location and extent of each system's circumstellar habitable zone. Two of these systems have planets that spend at least parts of their respective orbits in the system habitable zone: two of GJ 876's four planets and the planet that orbits HD 33564. We find that our value for GJ 876's stellar radius is more than 20 per cent larger than previous estimates and frequently used values in the astronomical literature

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand.

Background: Data on durability of first-line antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) are limited. We assessed time to switch to second-line therapy in 16 European countries and Thailand. Methods: Children aged <18 years initiating combination ART (≥2 nucleoside reverse transcriptase inhibitors [NRTIs] plus nonnucleoside reverse transcriptase inhibitor [NNRTI] or boosted protease inhibitor [PI]) were included. Switch to second-line was defined as (i) change across drug class (PI to NNRTI or vice versa) or within PI class plus change of ≥1 NRTI; (ii) change from single to dual PI; or (iii) addition of a new drug class. Cumulative incidence of switch was calculated with death and loss to follow-up as competing risks. Results: Of 3668 children included, median age at ART initiation was 6.1 (interquartile range (IQR), 1.7-10.5) years. Initial regimens were 32% PI based, 34% nevirapine (NVP) based, and 33% efavirenz based. Median duration of follow-up was 5.4 (IQR, 2.9-8.3) years. Cumulative incidence of switch at 5 years was 21% (95% confidence interval, 20%-23%), with significant regional variations. Median time to switch was 30 (IQR, 16-58) months; two-thirds of switches were related to treatment failure. In multivariable analysis, older age, severe immunosuppression and higher viral load (VL) at ART start, and NVP-based initial regimens were associated with increased risk of switch. Conclusions: One in 5 children switched to a second-line regimen by 5 years of ART, with two-thirds failure related. Advanced HIV, older age, and NVP-based regimens were associated with increased risk of switch

Refractive index of micro/nano structured dielectric materials

International audienc

Optical Characterization of thin films for gas sensors

June 27 – July 2 (2004), Tucson (Arizona, USA